Definition: Antiplatelet treatment is drug treatment that decreases platelet aggregation and
inhibit thrombus formation in the arterial circulation.
Four main types of antiplatelet drugs are available:
Aspirin — this irreversibly inhibits cyclo-oxygenase and blocks the production of
thromboxane.
Clopidogrel, prasugrel and ticagrelor — these are are thienopyridines, P2Y12
antagonists. They inhibit the binding of adenosine diphosphate to its platelet
receptor, this is thought to inhibit platelet aggregation by blocking activation of the
glycoprotein IIb/IIIa pathway.
Dipyridamole — this has both antiplatelet and vasodilatory properties. It inhibits
uptake of adenosine into erythrocytes, platelets, and endothelial cells, resulting in an
increased extracellular concentration of adenosine, which is a potent inhibitor of
platelet activation and aggregation. It may also act by inhibiting the breakdown of
cyclic guanosine monophosphate.
Glycoprotein IIb/IIIa inhibitors (for example, abciximab, eptifibatide, and tirofiban)
block the binding of fibrinogen to glycoprotein IIb/IIIa receptors on the platelet. They
are given intravenously in secondary care.
Complications:
Antiplatelet drugs increase the risk of bleeding, which can lead to complications such
as gastrointestinal bleeding.
The risk is further increased when antiplatelet drugs are used in combination with
one another or with drugs known to increase bleeding (for example, anticoagulants)
Management:
Primary prevention of CVD
Do not routinely prescribe antiplatelet treatment for the primary prevention of CVD
Consider prescribing aspirin in people with high risk of stroke or MI (perform QRISK)
People can reduce their risk of CVD by lifestyle changes, stop smoking, statins.
Advice people taking antiplatelets to tell their dentist before surgery.
Secondary prevention of CVD
Antiplatelet treatment should be prescribed for the secondary prevention of
cardiovascular events in people with:
Acute coronary syndrome (ACS).
Angina.
Atrial fibrillation (AF) — in these people anticoagulants are more usually prescribed.
Peripheral arterial disease (PAD).
Antiplatelet treatment should also be prescribed for the secondary prevention of
cardiovascular events in people after:
o Myocardial infarction (MI).
o Stent implantation.
o Stroke or transient ischaemic attack (TIA)
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller ssazinnasuleman. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $26.63. You're not tied to anything after your purchase.